Geo- good post on the yahoo NPHC board. Way to push back the emotional Frank haters. The cult like NPHC investors don't understand that Rik's burn rate prohibits him from hiring a big time distributor that will actually charge a steep monthly retainer AND commission. Big time distributors/retail brokers are going to put back the cost of marketing on NPHC as well. This isn't a big time biotech company (as Rik would like everyone to believe). XCHO is the best option for NPHC right now.
Though it would probably never happen-- I want to throw something out there for discussion. Frank has a very captive investment base. Apparently there are many soft commitments for any additional equity, if needed (private placement). However, he is sensitive to not diluting. Naturally, the inclination is to wait until the PPS is much higher to raise capital.
New capital can be used to start marketing new products, OR...(here is comes)- what if XCHO entirely buys the patent to Cobroxin or simply takes a huge investment in NPHC?
People can say what they want about XCHO and Frank. Truth is that XCHO owns the shelf space and platform that Cobroxin is currently on. The broker network is in place, and investors/lenders are clamoring to help XCHO execute. Frank might not be the best face man for a publicly traded company. However, he has built the infrastructure for some level of long term value. Now we need to start squeezing that intrinsic value...
